- $532.91m
- $546.97m
- $36.97m
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition
Brief: ClearPoint Neuro Q4 Operating Expenses USD 13.4 Million
ClearPoint Neuro prelim Q4 revenue rises
ClearPoint Neuro Q3 revenue up 9% driven by new customers
Brief: ClearPoint Neuro Q3 Revenue USD 8.9 Million
ClearPoint Neuro adds to gains, up 125% since Sept 23
Clearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
Clearpoint Neuro Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Clearpoint Neuro Inc QTRLY Loss Per Share $0.22
Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview
Clearpoint Neuro Inc reports results for the quarter ended December 31 - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview
Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview
Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview
Clearpoint Neuro Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Clearpoint Neuro Files For Common Stock Offering Of Up To $50 Million - SEC Filing
Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview